News

Boehringer Ingelheim announced data from the landmark 52-week DYNAGITO® trial which show that in people with COPD (chronic obstructive pulmonary disease), Spiolto®Respimat® (tiotropium/olodaterol 5/5µg) lowers the rate of moderate-to-severe exacerbations compared with Spiriva® Respimat® (tiotropium). The...

Aptar Pharma, a leading drug delivery systems provider, is proud to announce its leading role in the organization of the forthcoming 7th Innovative Drug Delivery Solutions Symposium (IDDS). The biennial conference is to be held this year at the...

Aptar Pharma, a leading global solution provider of innovative drug delivery systems, is pleased to be a Platinum Sponsor at RDD 2018, taking place from April 22 to April 26 at the JW Marriott Starr Pass Resort and Spa,Tucson,...

Vetter has won the 2018 ISPE Facility of the Year Award (FOYA) in the Facility of the Future category for its Center for Visual Inspection and Logistics. The renowned prize is awarded annually by the prominent industry...

New data from one of the largest prospective ongoing global studies examining the use of oral antithrombotics for stroke prevention in atrial fibrillation (AF) in clinical practice, GLORIATM-AF, were presented at the EHRA 2018, the annual congress of the...

Orchard Therapeutics, a clinical-stage biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, announced two key additions to its executive leadership team, appointing Jason Meyenburg as chief commercial officer and John Ilett...

An enzyme inhibitor developed by Bruce Hammock, PhD, professor of entomology, and colleagues at University of California (UC), Davis, reduced inflammation in the brains of mice born to mothers with maternal immune activation as described in a study (“Key...